A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasisLin Cai, Jianzhong Zhang, Yangfeng Ding et al.|British Journal of Dermatology|2024Cited by 21
Efficacy and Safety of TLL-018 in Moderate to Severe Chronic Spontaneous Urticaria Patients with Inadequate Response to H1 Antihistamine: Results from a Phase Ⅰb StudyQianjin Lu, Peiyu Sun, Bin Yang et al.|Journal of Allergy and Clinical Immunology|2024Cited by 8
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trialLunfei Liu, Min Zheng, Chunlei Zhang et al.|European Journal of Dermatology|2020Cited by 5
Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II TrialYan Zhao, Jianzhong Zhang, Litao Zhang et al.|Dermatology and Therapy|2025Cited by 2